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Abstract
Background: The choroid plexus epithelium (CPE) is a lobed neuro-epithelial structure that forms the outer blood-brain
barrier. The CPE protrudes into the brain ventricles and produces the cerebrospinal fluid (CSF), which is crucial for brain
homeostasis. Malfunction of the CPE is possibly implicated in disorders like Alzheimer disease, hydrocephalus or glaucoma.
To study human genetic diseases and potential new therapies, mouse models are widely used. This requires a detailed
knowledge of similarities and differences in gene expression and functional annotation between the species. The aim of this
study is to analyze and compare gene expression and functional annotation of healthy human and mouse CPE.
Methods: We performed 44k Agilent microarray hybridizations with RNA derived from laser dissected healthy human and
mouse CPE cells. We functionally annotated and compared the gene expression data of human and mouse CPE using the
knowledge database Ingenuity. We searched for common and species specific gene expression patterns and function
between human and mouse CPE. We also made a comparison with previously published CPE human and mouse gene
expression data.
Results: Overall, the human and mouse CPE transcriptomes are very similar. Their major functionalities included epithelial
junctions, transport, energy production, neuro-endocrine signaling, as well as immunological, neurological and
hematological functions and disorders. The mouse CPE presented two additional functions not found in the human CPE:
carbohydrate metabolism and a more extensive list of (neural) developmental functions. We found three genes specifically
expressed in the mouse CPE compared to human CPE, being ACE, PON1 and TRIM3 and no human specifically expressed CPE
genes compared to mouse CPE.
Conclusion: Human and mouse CPE transcriptomes are very similar, and display many common functionalities. Nonetheless,
we also identified a few genes and pathways which suggest that the CPE between mouse and man differ with respect to
transport and metabolic functions.
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Introduction
The choroid plexus epithelium (CPE) is a single neural cell
layer, which folds itself into a cauliflower-like structure, protruding
in the lateral, third, and fourth brain ventricles. On the basolateral
side, the CPE lines vascular stroma, while the apical side faces the
brain ventricles (reviewed in [1]). The CPE contains tight junctions
and forms the blood-CSF barrier (outer blood brain barrier) that
prevents passive diffusion of (large) molecules between the CSF
and the blood [2,3]. The CPE produces the cerebrospinal fluid
(CSF) and actively transports various molecules from the plasma
into the CSF and removes other molecules from the CSF [4–8].
The CPE also synthesizes and secretes proteins [9,10]. Hence, the
CPE plays a crucial role in the fluid pressure and balance in the
brain ventricles, metabolism of the brain, cellular functions of
neurons, immunological and inflammatory process, neurosignal-
ing, neuroprotection after ischemia, and neurodegeneration. The
CSF also forms a hydraulic cushion for the brain. Since the CPE is
the gate-keeper between the blood and CSF, the tissue is also an
interesting target for drug delivery into the CNS [11]. The balance
between CSF production and drainage determines the intracranial
pressure (ICP). In human, the CSF is primarily reabsorbed into
the venous blood through the lymphatic system along the olfactory
and optic nerves and through the arachnoid villi along the superior
sagittal sinus (reviewed in [12]).
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The CPE has been implicated in several neurological disorders,
including inflammatory and infectious diseases [13–15], trauma
[16], ischemic events [17], malignancies [18], Alzheimer’s disease
(AD) [19,20] and multiple sclerosis (MS) [21]. In AD, there is
stacking of b-amyloid in the CPE cells, the CPE cells have
impaired mitochondrial function and increased oxidative stress
[19,20]. Both the production and outflow of CSF decline in AD.
This results in a decreased CSF turnover and a changed CSF
composition [22–24]. Harmful molecules may than accumulate in
the CSF and disrupt brain homeostasis. In a subset of AD patients,
an impaired blood-CSF barrier was found, which could increase
the amount of harmful molecules in the CSF [25]. In MS, CPE
cells showed persisting immune activation with immunostaining
for T lymphocytes, HLA-DR, and VCAM-1 [21]. Malignancies
can originate from the CPE and are classified as follows: CPE
papilloma (grade I), atypical CPE papilloma (grade II), CPE
carcinoma (grade III), and CPE adenoma [18]. Interestingly, there
are indications that the CPE may also play a role in diseases at the
periphery of the brain, such as the ocular disorder primary open
angle glaucoma (POAG), via an altered CSF-pressure dynamics
[26–30]. POAG is a neurodegenerative disease of the optic nerve.
A major risk factor for POAG is an increased intraocular pressure
(IOP), but recent evidence suggests that a decreased ICP may be a
risk factor as well [26–30]. Consequently, damage to the optic
nerve in POAG may be caused by the net pressure force on the
optic disk, which is determined by the difference between the IOP
and ICP (reviewed in [31]).
Human diseases, like AD, MS and POAG, are frequently
studied in transgenic mouse models to understand the in vivo
biological effect of genetic variation and to develop experimental
therapies. As a first step towards constructing transgenic mice that
can serve as a model for disturbances in the CPE and CSF
formation, it is important to know whether a gene or function of
interest is similarly expressed between species. In order to answer
the question whether the mouse forms a good animal model to
study human CPE related disorders, we need to know the
similarities and differences in human and mouse CPE transcrip-
tomes. Consequently, we determined and compared the gene
expression profiles and functional annotation of the human and
mouse CPE using microarray hybridizations and the knowledge
database Ingenuity. We also made a comparison with previously
published human and mouse CPE gene expression datasets. In this
study, we aimed to answer the following three questions: (1) What
is the functional annotation of the human and mouse CPE? (2) Are
orthologous genes similarly expressed in human and mouse CPE?
(3) Are there human or mouse specifically expressed CPE genes?
Methods
1. Ethics statement
The human CPE material was obtained from the Netherlands
Brain Bank (NBB) (Amsterdam, the Netherlands). In accordance
with the international declaration of Helsinki, the NBB obtained
permission from the donors for brain autopsy and the use of
clinical information for research purposes. All procedures of the
NBB have been approved by the ethics Committee of VU
University Medical Center (Amsterdam, the Netherlands). The
human data were all analyzed anonymously.
The study on mouse brain material was carried out in strict
accordance with the recommendation in the Guide for the Care
and Use of Laboratory Animals under Dutch law, which is in
accordance with the international declaration of Helsinki. The
protocol was approved by the Committee on Ethical of Animal
Experiments of the Netherlands Institute for Neuroscience (NIN),
Royal Dutch Academy for Science (KNAW), the Netherlands.
2. Gene expression of the healthy human and mouse CPE
We collected seven human CP samples from the lateral
ventricles of the human brain. We processed the tissues between
6–24 hours post-mortem time. All tissues were processed anony-
mously. All donors were male and donor age varied between 51
and 73 years. The donors had no history of any brain disease and
post-mortem analysis of the brain revealed no amyloid plaques or
tangles (Braak stage zero).
Mouse CPE was obtained from three mouse brains of healthy
18–21 weeks old C57BL/6 mice. We selected adult human donors
and adult mice in order to make the comparison as reliable as
possible. The C57BL/6 mice (Harlan, Venray, the Netherlands)
were raised in a room with a temperature around 21uC, on a
12:12-h light-dark cycle, and fed with standard pellet laboratory
chow and water ad libitum. By the age of 18 to 21 weeks, they
were anesthetized with CO2/O2 and sacrificed with cervical
dislocation. The brains were embedded in Tissue Tec OCT, snap-
froze in liquid nitrogen and stored at 280uC until use.
We cut out selectively the CPE cells of the human and mouse
brain cryosections with laser dissection microscopy in order to
exclude contamination with adjacent tissues, like the vascular
stroma (PALM Carl Zeiss, Microlaser Technologies AG, Ger-
many). For the human CPE, we cut out 15 cryosections of 10 mm.
For the mouse CPE, we cut the whole brain in 20 mm thick
vertical slides and selectively laser dissected the whole CPE from
the lateral ventricles. We used Cresyl Violet staining to identify the
CPE cells. RNA isolation, amplification, and labeling procedures
were the same as previously described [32]. Quality of tRNA was
checked with BioAnalyzer assay (Agilent Technologies, Amstelv-
een, the Netherlands, RNA 6000 Pico Kit). RNA integrity
numbers (RIN’s) of human CPE tRNA ranged from 5.9 to 7.5
(average 6.4) and of the mouse CPE tRNA from 6.5 to 7.9
(average 7.3). We used a common reference study design with
RNA from, respectively, human and wild type mouse retinal
pigment epithelium/choroid as the common reference. We
hybridized seven human and three (genetically homogeneous)
mouse CPE samples against their common reference samples on,
respectively, catalogue human 4644K and mouse 1644K
microarrays (Agilent Technologies, Amstelveen, the Netherlands).
See Janssen et al. [32] for a detailed description of the laser
dissection procedures, RNA processing and microarray proce-
dures.
We submitted our microarray data to Gene Expression
Omnibus (GEO) database and the accession number is
GSE49974.
The microarray image files were analyzed and processed by
Agilent Feature Extraction Software (Agilent Technologies,
version 9.5.3.1) and mean intensities (log2) were given to the
spots. In R (version 2.14.0 for Windows, R Development Core
Team, 2009), we normalized the mean intensities between arrays
(NormalizeBetweenArrays with method ‘aquantile’). We ranked
the genes by expression level and assigned percentile ranks (P)
[33]. Next, we formed four sub-datasets: high expression
(expression .90th P), moderate expression (50–90th P), low
expression (10–50th P) and very low expression (,10th P). This
means that a gene in the high expression sub-dataset (.90th P) has
an expression intensity that falls into the highest 10% intensity
values of the microarray, whereas a gene in the very low
expression sub-dataset (,10th P) has an expression intensity in
the lowest 10% intensity values of the microarray (methodology
according to Booij [33]; Janssen [32]).
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3. Functional annotation of human and mouse CPE
We functionally annotated the ‘‘Human and Mouse High CPE
expression sub-datasets’’ with the knowledge database IPA
(Ingenuity Systems version 14855783; date of analysis between
December 2012–April 2013; www.ingenuity.com). We selected the
highly expressed genes for analysis since these genes are most likely
of biological importance [33]. IPA, commonly called ‘‘Ingenuity’’
is a knowledge database and bioinformatics program aimed at the
interpretation of gene expression data across species. An Ingenuity
‘core analysis’ typically generates biological functions, canonical
pathways and functional molecular networks. We set the relevant
statistical parameters in Ingenuity to Benjamini-Hochberg multi-
ple testing correction and statistical significance was set from p-
values,0.001. For the functional molecular networks, we set
Ingenuity software to build networks with maximum 35 molecules
and a maximum of 25 networks. For more detailed information on
Ingenuity see www.Ingenuity.com. We also compared the human
and mouse functional annotation of the different CPE gene
expression sub-datasets (high, moderate, low and very low
expression sub-datasets). We did this by making a list of all
significant functions attributed to, for example, the ‘‘Human High
CPE expression sub-dataset’’ and the ‘‘Mouse High CPE sub-
dataset’’. Next, we compared these lists, looking for potential
overlap or differences between assigned functions.
4. Human or mouse specifically expressed CPE genes
To discover human CPE genes that were specifically expressed
compared with the mouse CPE, we compared the ‘‘Human High
CPE expression sub-dataset (.90th P)’’ with the ‘‘Mouse Very
Low CPE expression sub-dataset (,10th P)’’ (Figure 1). We only
compared orthologous genes of human and mouse with the same
gene name annotation in Ingenuity, with the function ‘‘compare data’’.
We corrected for potential gene duplicates and selected only oligos
representing genes with a formal GenBank NM Accession
number. Array duplicate features that showed inconsistent
hybridization signals were also removed from the comparison.
We consider these genes that are highly expressed in human CPE,
and very lowly expressed in the mouse CPE, to be specifically
expressed in the human CPE.
Similarly, a comparison of the ‘‘Mouse High CPE expression
sub-dataset (.90th P)’’ with the ‘‘Human Very Low CPE
expression sub-dataset (,10th P)’’ yielded the genes that were
specifically expressed in the mouse CPE compared to human
CPE.
5. Confirmation of gene expression data by RT-PCR
We confirmed our microarray data with semi-quantitative RT-
PCR (sqRT-PCR). For sqRT-PCR, we selected five genes that
were substantially higher expressed in human CPE than in mouse
CPE. This meant that the genes were highly (.90th P) expressed
in human CPE and lowly (0–50th P) in mouse CPE. These five
genes were ANKK1, FBP2, ILDR1, NELL2, and THEM5. We also
selected five genes that were highly expressed in both human and
mouse CPE (ATP1B1, IGFBP7, NPC2, RPL13, and SLC13A4), and
five genes that were substantially higher expressed in mouse CPE
compared to human CPE (ACE, LBP, PON1, SLC7A10, and
TRIM3). The procedure of the sqRT-PCR was previously
described by Booij et al. [34]. In short, sqRT-PCR was carried
out using intron spanning primers on cDNA from laser dissection
microscopy derived samples of human and mouse CPE. Since we
worked with human post-mortem donor material which consists of
intrinsically shorter and partly degenerated RNA fragments, we
could not use catalogues RT-PCR assays, and we had to generate
primers near the 39 end of the gene. Because of this sub-optimal
primer design, PCR was not always optimal and some cDNAs
showed no PCR product at all. The primer sequences used are
available on request.
6. Comparison with other gene expression datasets of
the CPE from the literature
We compared our gene expression of the healthy human and
mouse CPE with those of previously published CPE gene
expression datasets. Obviously, these literature microarray studies
had their own strengths and limitations in terms of method of
sample isolation, RNA quality control and processing, number
features screened, data analysis, and interpretation. We transferred
the literature datasets into our own data structure to make all data
and studies maximally comparable. We used literature gene
expression database of healthy human CPE (GSE14098 [35]) and
three of healthy mouse CPE (GSE23714 [36]), GSE37098,
GSE33009 [37]). For each of these gene expression datasets, we
selected the highly expressed genes (.90th percentile), as
described above (Methods paragraph 2). We functionally anno-
tated these highly expressed sub-datasets and compared the
analyses with ours.
Results
1. Gene expression of human and mouse CPE
Our gene expression data of the human and mouse CPE can be
found in the GEO database (GSE49974). For both the human and
mouse CPE, we ranked the genes in four different sub-datasets:
high, moderate, low and very low expression (see Methods). We
selected the ‘‘Human and Mouse High CPE expression sub-
datasets’’ (.90th P) (number of genes, respectively, n = 3361 and
n=3699) for further functional annotation and determined
potential human and mouse specifically expressed CPE genes.
We also analyzed genes that were highly (.90th P) expressed in
one species and simultaneously low in the other species and we
studied the genes of the very low CPE expression sub-datasets
(,10th P; number of genes human n= 3179 and mouse n= 3583).
These two latest analyses did not lead to additional interesting
information and are therefore not shown.
Figure 1. Human specifically expressed CPE genes. Schematic
graph to illustrate the determination of the human specifically
expressed CPE genes compared to mouse CPE. We compared the
‘‘Human High CPE expression sub-dataset (.90th P)’’ with the ‘‘Mouse
Very Low CPE expression sub-dataset (,10th P)’’ and selected the
common genes that showed consistent hybridization signals and had a
formal GenBank NM number. These genes, indicated in the orange
overlapping area, are called the human specifically expressed CPE
genes.
doi:10.1371/journal.pone.0083345.g001
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2. Functional annotation of our ‘‘Human High CPE
expression sub-dataset’’
Functional annotation of gene expression datasets using the
Ingenuity knowledge database yields biological functions, canonical
pathways, and functional molecular networks.
For our ‘‘Human High CPE expression sub-dataset’’ the major
seven biological functions were: (1) neurological function and disease,
including Alzheimer’s disease, Parkinson’s disease, Huntington’s
disease, Leigh syndrome, mitochondrial cytopathy, hydrocephalus,
neuromuscular disease, tauopathy, gliosis, and nervous system
development; (2) immunological and inflammatory function and
disease, including viral infection pathways, rheumatoid arthritis,
psoriasis, and auto-immune disease; (3) developmental function
and disease, including adhesion of embryonic cells, proliferation of
fibroblasts and muscle cells, adhesion of kidney cells, and
morphology of neuroglia; (4) hematological function and disease,
including hematopoiesis, anemia, erythrocytosis, Fanconi anemia,
and Diamond-Blackfan anemia; (5) free radical scavenging; (6)
energy production; and (7) basic cellular (dys)functions, including
gene expression, protein synthesis and degradation, cell cycle,
molecular transport, cell-to-cell signaling, cellular movement, and
cancer.
Functional annotation of our ‘‘Human High CPE expression
sub-dataset’’ also yielded statistically significant canonical pathways.
We subdivided those in seven groups: (1) actin cytoskeletal
function; (2) epithelial junctions; (3) vesicle mediated transport;
(4) oxidative stress pathways; (5) immunological function; (6)
endocrine signaling and metabolism; and (7) basic cellular
(dys)functions (Table S1).
We next analyzed the 25 functional molecular networks that
Ingenuity assigned to our ‘‘Human High CPE expression sub-
dataset’’ (Table S2). Functional annotation of these networks
included developmental functions and hereditary disorders,
cellular transport functions and diseases in hematological,
metabolic, connective tissue, cardiovascular, and endocrine
systems. Figure 2 presents, as an example, network 8, which
contained several genes involved in hematological and neurolog-
ical disorders. Another example is network 16 (Figure 3), which
contained many entries involved in transport.
3. Functional annotation of our ‘‘Mouse High CPE
expression sub-dataset’’
The functional annotation of our ‘‘Mouse High CPE expression
sub-dataset’’ yielded similar biological functions compared to the
human analysis (described above). Furthermore, we found unique
biological mouse CPE functions, not present in the ‘‘Human High
CPE expression sub-dataset’’, being (A) metabolic function and
disease, including carbohydrate metabolism, lipid metabolism,
aciduria, mitochondrial disorder hyperglycemia, hyperinsulinism,
hypoglycemia, and amyloidosis; and (B) a more extensive list of
developmental functions, including development and morphology
of the brain, eye, and cardiovascular system, as well as fusion of
fetal membranes and embryo-size.
For our ‘‘Mouse High CPE expression sub-dataset’’, we
identified the same canonical pathways as we found in the ‘‘Human
High CPE expression sub-dataset’’. In addition, we made the
following observations: First, there were far more statistically
significant canonical pathways in our ‘‘Mouse High CPE
expression sub-dataset’’. All these additional pathways were
categorized into the seven groups mentioned above (see functional
annotation of the ‘‘Human High CPE expression sub-dataset’’),
except for ‘‘Mouse embryonic stem cell pluropotency’’. Further-
more, the vesicle mediated transport pathway ‘‘Clathrin-mediated
endocytosis signaling’’ was only statistically significant in our
‘‘Mouse High CPE expression sub-dataset’’ (Figure 4), whereas
‘‘Caveolin-mediated endocytosis signaling’’ was statistically signif-
icant in both our ‘‘Human and Mouse High CPE expression sub-
datasets’’. Finally, our ‘‘Mouse High CPE expression sub-dataset’’
displayed more metabolic canonical pathways, for example ‘‘Fatty
acid beta-oxidation I’’ and ‘‘TCA cycle II’’. Table S1 presents an
overview of all statistically significant canonical pathways of the
‘‘Human and Mouse High CPE expression sub-datasets’’.
For our ‘‘Mouse High CPE expression sub-dataset’’, Ingenuity
built 25 functional molecular networks with functionalities including
development and hereditary disorders, metabolism of glucose and
lipids, hematological disease, neurological disease, connective
tissue disease, and ophthalmic disease (Table S3). An example is
network 20 (Figure 5), which contained several genes involved in
glucose metabolism. Another example is network 23 (Figure 6),
which contained many genes previously implicated in develop-
mental processes.
4. Human and mouse specifically expressed CPE genes
4.1. Human specifically expressed CPE genes. Following
our strict selection criteria, we compared our ‘‘Human High CPE
expression sub-dataset’’ with our ‘‘Mouse Very Low CPE
expression sub-dataset’’: we did not find any gene(s) specifically
expressed in the human CPE compared to the mouse CPE.
4.2. Mouse specifically expressed CPE signature
genes. We found three genes that were specifically expressed
in the mouse CPE compared to human CPE, namely ACE, PON1
and TRIM3 (Table 1).
5. Confirmation of gene expression data by PCR
For all 14 selected genes (ANKK1, FBP2, ILDR1, NELL2,
ATP1B1, IGFBP7, NPC2, RPL13, SLC13A4, ACE, LBP, PON1,
SLC7A10, and TRIM3), the positive controls were indeed positive
(not shown). The positive control samples included placenta,
cortex, and liver cDNA samples. For 12 genes, we could directly
confirm our gene expression data with sqRT-PCR (Figure 7). For
THEM5, we could not design optimal primers (see Methods
section). A few primer sets did not yield PCR product for positive
controls of human and mouse CPE. So we excluded this gene from
the list. The PCR of the genes ANKK1 and ILDR1 were suggestive
but not significant confirmative.
6. Comparison with other gene expression datasets of
the CPE
We compared our gene expression data of the human and
mouse CPE with those of previously published CPE gene
expression data, namely one healthy human CPE (GSE14098
[35]) and three healthy mice CPE (GSE23714 [36]; GSE37098;
GSE33009 [37]). The characteristics of these datasets as well as
ours are presented in Table 2. For these additional four gene
expression datasets, we also selected the highest expressed genes
(.90th P) (see Methods) and we conducted a functional
annotation of the sub-datasets in Ingenuity comparable to our
own analyses described above.
Within the limitations of each study, there was substantial
overlap between our ‘‘Human and Mouse High CPE expression
sub-datasets’’ and previously published data. Also their functional
annotations per species were highly similar. The three functions
that we found in mouse CPE but not in human CPE, were, in part,
confirmed (metabolism and more extensive list of developmental
functions) and, in part, not (clathrin-mediated endocytosis
signaling). For the three specifically expressed mouse CPE genes
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compared to human CPE, we found high expression of ACE and
moderate expression of PON1 and TRIM3 in all mouse CPE gene
expression datasets. We identified low expression of TRIM3 in the
human CPE expression dataset GSE14098; for ACE and PON1, no
additional human CPE data were available in GSE14098. The
detailed comparison is summarized in Table 3.
Discussion
In the present study, we investigated and compared the gene
expression profiles and functional annotations of healthy human
and mouse CPE.
The expression of most of the orthologous CPE genes is highly
similar between human and mouse. In contrast with the human
CPE, the mouse CPE specifically expressed three genes, namely
ACE, PON1 and TRIM3.
We found that the functional annotations of human and mouse
CPE are highly comparable, with respect to presence of epithelial
junctions, transport, energy production, neuro-endocrine signal-
ing, and immunological, neurological and hematological functions
and disorders. The mouse CPE also presented two additional
functions not found in the human CPE, namely carbohydrate
metabolism pathways and a more extensive list of (eye and neural)
developmental functions.
1. Study design of CPE gene expression
The technical and methodological strengths and limitations of
our microarray approach were already extensively discussed
elsewhere [33,38]. In short, the strengths include inclusion of
seven different human donor tissues, use of a laser dissection
microscope for high cellular specificity and minimal tissue
manipulation, large scale analysis using a 44k microarray and a
common reference design for normalization between the samples.
A limitation is that we used post-mortem human material. To
correct for this, we stringently controlled sample and RNA quality
(as measured by RNA RIN values) in every step of the protocol
and we used standardized catalogue arrays with many internal
controls. Furthermore, we focused our analysis of groups of genes
with a wide range of expression levels and a single specific
function, rather than on individual gene expression levels alone.
Another limitation is that our cut of criteria for high and low
expression levels are arbitrary.
For the current study, some additional consideration and
choices were made. Gene expression profiles of human and mouse
CPE were studied on catalogue whole-genome microarrays
(Agilent) that were separately designed for human and mouse
orthologous genes but do not target exactly the same gene
sequence. Therefore, the human and mouse probes have different
affinities to their target RNAs and this hampers a direct comparison
between human and mouse RNA expression data. To solve this
Figure 2. Molecular network generated by the Ingenuity software from the ‘‘Human High CPE expression sub-dataset’’. Example of a
molecular network generated by Ingenuity from the ‘‘Human High CPE expression sub-dataset (.90th P)’’ of the microarray analysis. Grey symbols
represent genes that are highly expressed in the human CPE. Transparent entries are molecules inserted by the knowledge database. Abbreviations
of gene names are according to standard abbreviations used in GenBank. Solid lines between molecules indicate direct physical or functional
relationships between molecules (such as regulating and interacting protein domains); dotted lines between molecules indicate indirect functional
relationships (such as co-regulation of expression of both genes in cell lines). The genes CEBPB, CP, RPL5, RPL13, RPL28, and RPS14 were previously
implicated in microcytic and Diamond-Blackfan anemia and myelodysplastic syndrome and the genes RPL5, RPL13, RPL13A, and RPS4X were
previously implicated in Parkinson’s disease and motor neuropathy (these genes are indicated bold in the Figure). The main functionalities given by
Ingenuity for this entire molecular network are ‘Cancer and hematological and metabolic disease’.
doi:10.1371/journal.pone.0083345.g002
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problem, we choose to rank the gene expression data and
subdivided the total dataset in four different expression groups:
high, moderate, low and very low expression, essentially according
to Booij et al 2009. For each gene, a rank number according to this
subdivision was given, which made comparison of relative gene
expression levels between mouse and human possible. By
comparing the most extreme sub-datasets, namely the high
(.90th P) and very low (,10th P) between species, we could
identify physiological relevant differences between human and
mouse CPE gene expressions, since these major differences could
not be caused by different affinities alone. Furthermore, the three
mouse specifically expressed CPE genes compared to human CPE
were confirmed with sqRT-PCR. Other strategies with a number
of other (dis) advantages exist to compare human and mouse
expression data. These were based on the comparison between
diseased and healthy human and mouse tissues [39,40], or the
comparison between more than two tissues of human and mouse
[41] or on many different tissues together and with the major goal
to study overall homology between human and mouse, without
tissue-specific questions [42–44]. A full methodological description
comparing all (dis-)advantages is outside the scope of this paper.
However, with our approach healthy human and mouse CPE
expression profiles can be compared specifically and in detail.
2. Functional annotation of human and mouse CPE
2.1 Common functionalities of human and mouse
CPE. The most important common functionalities of the human
and mouse CPE, based on our gene expression dataset, were:
presence of epithelial junctions, transport properties, energy
production and oxidative stress, neuro-endocrine signaling, and
immunological, neurological and hematological function and
disease.
The expression of genes coding for epithelial junctions were highly
comparable between human and mouse CPE. The epithelial
junction genes showed overlap in expression category between
Figure 3. Molecular network generated by the Ingenuity software from the ‘‘Human High CPE expression sub-dataset’’. Example of a
molecular network generated by Ingenuity from the ‘‘Human High CPE expression sub-dataset (.90th P)’’ of the microarray analysis. For explanation
of symbols on the diagrams see legend Figure 2. This network contains several genes that code for proteins involved in transport of specific
biomolecules, namely CYTB and UQCR11 (transport of H+), MUT and NFE2L1 (transport of glutathione and carnitine), VDAC3 (transport of adenine) and
C1QBP (transport of hyaluronic acid and lactic acid). The genes mentioned are indicated bold in the Figure. The main functionalities given by
Ingenuity for this entire molecular network are ‘Hereditary disorder, metabolic disease and molecular transport’.
doi:10.1371/journal.pone.0083345.g003
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human and mouse CPE, and none showed a difference in
expression more than one sub-dataset between human and mouse
(Figure 8). Taken together, our data thus suggest that there may be
minor expression differences in CPE cell adherence genes between
human and mouse. Future, more specific physiological studies
should make it clear whether these minor expression differences
ultimately translate themselves into high similarities in CPE
barrier function between these two species.
We also compared the previously published human and mouse
CPE datasets with respect to the expression profiles of the
epithelial junctions. These were highly similar with our data. For
example, we found high expression of CTNNA1 and CTNNB1 in
all gene expression datasets, moderate to high expression of GJA1
and TJP1 in human CPE and moderate to high expression of
CLDN1 and CLDN2 in all mouse CPE gene expression datasets.
Obviously, transporters play an important role in the CPE.
Besides the production of CSF, the CPE also transports a variety
of biomolecules and acts as a sink for xenobiotics.
Previously, Brown et al. [45] reviewed the ion-channel proteins
in the CPE that are involved in CSF production. We now
identified the expression of the genes corresponding to these ion
channel proteins in all human and mouse CPE gene expression
datasets available to us (Table 4). Overall, the gene expression
values were highly comparable, not only between different studies
but also between species. Some of these ion-channel genes were
highly expressed across all datasets, namely AQP1, ATP1A1,
ATP1A2, ATP1B1, ATP1B2, ATP1B3 and SLC12A2. There were
also some genes that tended to be higher expressed in the human
CPE compared to the mouse CPE (KCNA5) or higher in mouse
CPE compared to human CPE (CLCN4, KCNAB2, KCNH1,
KCNK3, SLC12A4, SLC4A2 and SLC4A8). These findings confirm
previously published data on the molecular transport mechanisms
in the CPE [37,46].
Functional annotation of all human and mouse CPE gene
expression datasets, yielded significant functionalities implicated in
energy production and oxidative stress pathways. Indeed, the CSF
production and transport of many biomolecules over the CPE is
ATP-driven and therefore the CPE requires large amounts of
energy. The high energy demand of the CPE is met by the
intracellular presence of a surplus of mitochondria [47,48]. Energy
producing mitochondrial pathways inevitably generate free
radicals and oxidative stress.
Functional annotation of our data-driven gene expression
analysis confirms that the CPEs in both men and mice are
involved in neuro-endocrine signaling. Indeed the CPE transports
many signaling molecules from the blood to the CSF, which are
implicated in CSF formation, water balance, neuronal function
and brain metabolism, protection, and degeneration (reviewed in
[49]). Furthermore, the CPE itself also synthesizes and secretes
neuro-endocrine signaling molecules (reviewed in [50]) that can
regulate CSF production, for example in case of dehydration [11].
In our expression datasets of human and mouse CPE we found, for
example, high expression of APOE, APOD, BMP6, FGF2, FGF18,
FGFR2, GSN, IGF2, IGFBP2, TGFB2, TTR, VEGFA, and VEGFB.
These genes were also moderately to high expressed in most of the
other human and mouse CPE gene expression sub-datasets. The
expression of many of these signaling molecules in both mouse and
human CPE indicates that their neuro-endocrine signaling
functions are also highly similar.
Figure 4. Clathrin-mediated endocytosis signaling pathway identified by the Ingenuity software in the ‘‘Mouse High CPE
expression sub-dataset’’. This is one of the canonical pathways that contained statistically significantly more genes than expected by chance in
the group of genes that are highly expressed in the mouse CPE. Gray fields indicate their presence in the ‘‘Mouse High CPE expression sub-dataset
(.90th P)’’; uncolored genes are added by the Ingenuity software to show the entire standard pathway. Solid lines between molecules indicate direct
physical relationships between molecules (such as regulating and interacting protein domains). Abbreviations of gene names are according to
standard abbreviations used in GenBank. As shown, the majority of genes of this pathway are highly expressed in the mouse CPE.
doi:10.1371/journal.pone.0083345.g004
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The analysis of our ‘‘Human and Mouse High CPE expression
sub-datasets’’ and those of the literature, yielded several significant
biological functions and canonical pathways involved in immuno-
logical and inflammatory processes, in viral infection, lichen planus,
arthritis and auto-immune disease. Genes involved in these
functionalities and highly expressed in our human and mouse
CPE datasets were, for example, ANXA5, 26, ATOX1, CFH, CD9,
CD24, CD63, CDH11, HLA-B, HIST1H1C, HSPA5, HYAL, IGF2,
IGF1R, IGFBP2, 25, 27, and ITGAV. Indeed, according to the
literature, the CPE is an important importer of T-cells and virus
particles into the CNS [51–53] and is involved in autoimmune
inflammation in multiple sclerosis [21].
In both our own and the literature’s ‘‘Human and Mouse High
CPE expression sub-datasets’’, we annotated several significant
biological functions relevant for neurological function and disease.
Examples were AD, Parkinson’s disease, and hydrocephalus.
Indeed, the CPE might be involved in AD by disturbances of CSF
production and composition [22–24], by disturbances of b-
amyloid clearance [4] and breakdown of blood-CSF barrier
[25]. Histological changes of the CPE in AD have been observed
and included epithelial atrophy, lipofuscin vacuoles, and basement
membrane thickening [19,20] (reviewed in [54]). We also found
high expression in the human and mouse CPE of the genes CA2,
CA12, and CA14, coding for carbonic anhydrases which are
involved in regulation of CSF production. Carbonic anhydrase
inhibitors decrease CSF production [55] and drugs like acetazo-
lamide, a CA inhibitor, are used as a treatment for some types of
hydrocephalus [56,57].
The hematological function that we found in both human and
mouse CPE involved two functions: iron transport and the ability
of extramedullary hematopoiesis in the CPE. Several studies
suggested that the CPE is a major player in the iron homeostasis of
the brain and in fact expresses all the entries known to participate
in the modulation of iron homeostasis in the periphery (TFR1,
DMT1, DCYTB, FPN, HJV, HFE, TFR2, FTH, FTL, TF,
hephaestin, and ceruloplasmin) [8,58]. Our gene expression data
Figure 5. Molecular network generated by the Ingenuity software from the ‘‘Mouse High CPE expression sub-dataset’’. Example of a
molecular network generated by Ingenuity from the ‘‘Mouse High CPE expression sub-dataset (.90th P)’’ of the microarray analysis. For explanation
of symbols on the diagrams see legend Figure 2. The genes PFKL, PFKM and PFKP were previously implicated in glucose metabolism and CA2, CA12
and CA14 were attributed to diseases with disturbed lipid and/or glucose metabolism and are involved in CSF production. These genes are indicated
bold in the Figure. The main functionalities given by Ingenuity for this entire molecular network are ‘Carbohydrate metabolism, ophthalmic disease
and metabolic disease’.
doi:10.1371/journal.pone.0083345.g005
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of human and mouse CPE and those of the literature corroborate
this hypothesis.
Extramedullary hematopoiesis (EH) is a compensatory mecha-
nism of hematopoiesis in other places than the bone marrow. EH
is seen in patients with prolonged anemia, for example in
thalassemia, sickle cell anemia, hemolytic anemia, and ineffective
erythropoiesis. Some well known places for EH are the liver,
spleen, and lymph nodes but also the choroid plexus was described
in several human case reports [59–61] and in dogs [62]. Our gene
expression data indicate that genes involved in hematopoiesis are
indeed highly expressed in the CPE of both the human and mouse.
2.2. Functions of the human CPE not annotated in mouse
CPE. We did not identify human specific CPE functions that
were not found in the mouse CPE.
2.3. Functions of the mouse CPE not annotated in human
CPE. The three major functionalities that were present in our
‘‘Mouse High CPE expression sub-dataset’’ and did not, or less,
occur in our ‘‘Human High/Moderate CPE expression sub-
datasets’’, were: carbohydrate metabolism, more extensive list of
(eye and neural) developmental functions and clathrin-mediated
endocytosis. Analysis of comparable datasets in the literature
confirmed the two first observations, but contradicted the last one.
Figure 6. Molecular network generated by the Ingenuity software from the ‘‘Mouse High CPE expression sub-dataset’’. Example of a
molecular network generated by Ingenuity from the ‘‘Mouse High CPE expression sub-dataset (.90th P)’’ of the microarray analysis. For explanation
of symbols on the diagrams see legend Figure 2. In this network there are genes involved in maturation of embryonic stem cells, generation of
dopaminergic neurons and survival of RPE cells (BCL2L1), size of the eye (AES, TLE1), development of neural crest (MSX1), morphogenesis of cartilage
tissue and middle ear (MSX1), and apoptosis of the embryoblast (TAF10). These genes are indicated bold in the Figure. The main functionalities given
by Ingenuity for this entire molecular network are ‘Gene expression, embryonic and organ development’.
doi:10.1371/journal.pone.0083345.g006
Table 1. Mouse specifically expressed CPE genes compared
to human CPE.
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Figure 7. Confirmation of microarray results by sqRT-PCR. Beta actin, a household gene, was used to normalize gene expression in the
human and mouse CPE. With semi quantitative RT-PCR (sqRT-PCR), we could confirm our microarray results, namely two genes that were
substantially higher expressed in human CPE compared to mouse CPE (FBP2 and NELL2), five genes that were highly expressed in both human and
mouse CPE (ATP1B1, IGFBP7, NPC2, RPL13, and SLC13A4) and five genes that were substantially higher expressed in mouse CPE compared to human
CPE (ACE, LBP, PON1, SLC7A10, and TRIM3). For all genes, positive controls were positive. For example, the primer set for human ACE did showed PCR
product in the positive control sample of placenta cDNA, and when we performed PCR in human CPE sample, we found no PCR product for ACE,
indicating that there was hardly any RNA of ACE in the human CPE. This was in correspondence of the microarray data. Black bars indicate human CPE
expression and grey bars mouse CPE expression. Standard deviations were calculated and indicated in the bars.
doi:10.1371/journal.pone.0083345.g007
Table 2. Basic characteristics of different human and mouse gene expression datasets.
Species M/F Age n GEO Platform N6 genes total
N6 genes .90th
P
Human M 51–73 y 7 GSE49974 Agilent-014850 Whole Human
Genome Microarray 4644K G4112F
(GPL4133)
33.469 2.722
Human ? ? 8 GSE14098 Affymetrix Human Genome U133A 2.0
Array (GPL571)
13.384 1.106
C57BL/6 mice F 18–21 wks 3 GSE49974 Agilent-012694 Whole Mouse
Genome G4122A (GPL2872)
33.542 3.467
C57BL/6 mice M 8–9 wks 3 GSE23714 Illumina mouseRef-8 v1.0 expression
beadchip (GPL6100)
19.077 1.277
C57BL/6J mice M 3 wks 5 GSE37098 Affymetrix Mouse Gene 1.0 ST Array
(GPL6246)
35.558 2.271
Webster mice F 10 wks 3 GSE33009 Affymetrix Mouse Exon 1.0 ST Array
(GPL6096)
23.332 1.741
Basic characteristics of our healthy human and mouse CPE gene expression datasets (bold printed) and those from previously published healthy human and mouse CPE.
Abbreviations: M=male; F = female; y = years; wks =weeks; n = number of sample size; Nu=number of; P = percentile.
doi:10.1371/journal.pone.0083345.t002
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Table 3. Comparison of different human and mouse CPE gene expression analysis.
Datasets Total1 Overlap2 Funct. Annot.3Metab4 Dev4 Clath4 ACE5 PON15 TRIM35
Human- GSE49974 3361 2 2 2 VL VL VL
Human- GSE14098 1106 787 (71%) h-s 2 2 + x x L
Mouse-GSE49974 3699 + + + H H H
Mouse- GSE23714 1277 1072 (84%) h-s + + + H M M
Mouse- GSE37098 2271 1450 (64%) h-s + + + H M M
Mouse- GSE33009 1741 1110 (64%) h-s + + + H M M
Comparison of our (bold printed) human and mouse CPE gene expressions, functional annotation and specifically expressed genes with those of previously published
human and mouse CPE transcriptomes.
1Total numbers of genes in the High Expression (.90th percentile (P)) sub-datasets.
2Comparison of the genes in the.90th P of different datasets from literature with our ‘‘Human and Mouse High CPE expression (.90th P) sub-datasets’’ per species. The
number and percentage of overlap is given.
3Comparison of the functional annotation (Funct. Annot); h-s = highly similar.
4Comparison with mouse specific functions. Metab =Metabolism: metabolic function and diseases, including carbohydrate metabolism, lipid metabolism, aciduria,
mitochondrial disorder, hyperglycemia, hypoglycemia and amyloidosis. Dev =Development: More extensive list of developmental functions, including development of
eye, cornea, cortex, brain and embryo-size. Clath =Clathrin: Clathrin-mediated endocytosis signaling.
5Comparison with specifically expressed genes. We identified three genes that we specifically expressed in mouse CPE compared to the human CPE, namely ACE, PON1
and TRIM3. We subdivided the gene expression data of human and mouse CPE from literature also in groups based on percentiles (P): high (H) (.90th P), moderate (M)
(50–90th P), low (L) (10–50th P) and very low (VL) (,10th P) and we looked in which of these groups the three genes were expressed in the gene expression databases
from literature. Sometimes, no data were available for a gene (indicated with ‘‘x’’).
doi:10.1371/journal.pone.0083345.t003
Figure 8. Expression of epithelial junction genes in human and mouse CPE. This diagram illustrates the distribution of expression of
epithelial junction genes in human and mouse CPE, subdivided in the four sub-datasets (very low (,10th P); low (10–50th P); moderate (50–90th P);
and high (.90th P); see Methods). On the x-axis, the four different expression subgroups are displayed, on the y-axis the number of genes. The black
solid lined circles contain epithelial junctions expressed in human CPE expression data and the grey dotted lined circles include those of the mouse
CPE. The epithelial junction genes showed overlap in expression category between human and mouse CPE, and none of them showed a difference in
expression more than one sub-dataset between human and mouse. For example, the genes CDH1 and CDH3 were highly expressed in human CPE
and moderately in mouse CPE, whereas the genes CLDN2 and CLDN3 were highly expressed in mouse CPE and moderately in human CPE and the
gene CTNNB1 was highly expressed in both human and mouse CPE.
doi:10.1371/journal.pone.0083345.g008
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Table 4. CPE gene expression of ion channel proteins implicated in CSF production.
Gene H1 H2 M1 M2 M3 M4 Gene H1 H2 M1 M2 M3 M4 Gene H1 H2 M1 M2 M3 M4
AQP1 H M H H H H KCNF1 M L M L L L KCNS1 L - L L L L
AQP10 L - - - - - KCNG1 L - - - M - KCNS2 L - L L L L
AQP11 M - M M M M KCNG2 VL - - - M - KCNS3 M M L L M M
AQP12 L - L L L L KCNG3 L - L L L L KCNT1 L - L - M -
AQP2 M - L M M M KCNG4 L - L M L L KCNV1 VL - VL L L L
AQP3 M M M L L L KCNH1 L - M H H H KCNV2 M - L L L L
AQP4 M L M M M M KCNH2 M L M M M H SCN10A VL L L L L L
AQP5 M - M L M M KCNH3 L - M L L M SCN11A L L M L L L
AQP6 L L L M L L KCNH4 L - - - L - SCN1A L L L VL L L
AQP7 L - L M L L KCNH5 L - VL - L L SCN1B L L M L L -
AQP8 L - L L L L KCNH6 L L L - L - SCN2A L L L - L -
AQP9 L - L L L L KCNH7 M - L L L L SCN2B L - M - L M
ATP1A1 H H H H H H KCNH8 L - VL VL L - SCN3A L L L L L L
ATP1A2 H M H H H H KCNJ1 L - L L L L SCN3B L L M VL L M
ATP1A3 H VL M - M M KCNJ10 M - M L M M SCN4A L - M L L L
ATP1A4 M - - - L - KCNJ11 L - M L L L SCN4B M - - - L L
ATP1B1 H H H H H H KCNJ12 L - M L L L SCN5A L - M M L L
ATP1B2 H M H H H H KCNJ13 H H - - H - SCN7A L - L VL L L
ATP1B3 H H H H H H KCNJ14 M L M M L L SCN8A L - M L L L
CLCN1 L - L L L L KCNJ15 L L L L L L SCN9A L - L VL L L
CLCN2 M - M M M M KCNJ16 L M L L L L SCNN1A M M M M L M
CLCN3 M M M M M H KCNJ2 M M L L L L SCNN1B L - M M L L
CLCN4 L M H M H H KCNJ3 L L L L L M SCNN1D L - - - - -
CLCN5 L L M L M M KCNJ4 L - M L L M SCNN1G VL - L L L L
CLCN6 M - M L M M KCNJ5 L VL M L L L SLC12A1 L - M L L L
CLCN7 M L M M M M KCNJ6 L - L L L L SLC12A2 H M H H H H
CLCNKA M - L M L M KCNJ8 H M M M M M SLC12A3 L L M L L L
CLCNKB L - L M L L KCNJ9 L - M L L L SLC12A4 M L H M H H
KCNA1 VL VL M L L M KCNK1 H M H H H H SLC12A5 L L M L M M
KCNA10 L - - - L - KCNK10 L VL - - L L SLC12A6 L L M M L M
KCNA2 L - M VL M M KCNK12 L - L L M M SLC12A7 H M M M M M
KCNA3 L - VL M M M KCNK13 M - L M L L SLC12A8 L M L L L L
KCNA4 L - L L L L KCNK15 M - - - L - SLC12A9 M L M M M M
KCNA5 H M L VL L L KCNK16 L - L - L - SLC4A1 L - M L L L
KCNA6 L L M M L L KCNK17 L - - - - - SLC4A10 H L H L H H
KCNA7 L - L VL L L KCNK18 VL - - - M L SLC4A11 - - L - M -
KCNAB1 M M M L L M KCNK2 L - L L L M SLC4A2 M L H H H H
KCNAB2 L L M M M M KCNK3 L L M L M M SLC4A3 M - M M M M
KCNAB3 M VL M M L L KCNK4 L - M L M M SLC4A4 M M L L M M
KCNB1 M L M L L M KCNK5 M VL M L L L SLC4A5 M L - - H -
KCNB2 VL VL L - L - KCNK6 L - L - L - SLC4A7 M M M M M -
KCNC1 L - M L L L KCNK7 M - M M L L SLC4A8 L L M M M M
KCNC2 L - L - L - KCNK9 L - - - L - SLC4A9 L - L L L L
KCNC3 M - M M M M KCNN1 L VL M L M M SLC9A1 L - M M M M
KCNC4 L - L L M M KCNN2 M M M M L L SLC9A10 - - VL - VL VL
KCND1 L - L L L L KCNN3 M - L L L M SLC9A2 L - L L L -
KCND2 L - M L L M KCNN4 L - M M L L SLC9A3 VL - L VL L -
KCND3 M L L L M M KCNQ1 M - M M M L SLC9A5 M - - - L -
KCNE1 M - L M L L KCNQ2 L - VL - L L SLC9A6 M M M L H H
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Thus, clathrin-mediated endocytosis in human and mice CPE may
be less different than initially suggested by our data.
Several carbohydrate metabolism genes involved in metabolism
of monosaccharide and carbohydrate and hyperglycemia (e.g.
CPT1A, GALK1, INS, LEPR, PRLR and SCD) are highly expressed
in mouse CPE and only lowly in human CPE. Although we can
detect, due to our study design, only consistent differences between
mice and men, it is not clear whether these differences are inborn
or are due to a (consistent) difference in aging or diet.
The exact meaning of these findings needs further investigation.
3. Human and mouse specifically expressed CPE genes
3.1. Human specifically expressed CPE genes. With our
strict selection criteria, we did not find any human specifically
expressed CPE gene compared to mouse CPE.
3.2. Mouse specifically expressed CPE genes. We iden-
tified three genes specifically expressed in the mouse CPE, namely
angiotensin-converting enzyme (ACE), serum paraoxonase/aryles-
terase 1 (PON1) and tripartite motif-containing protein 3 (TRIM3).
These findings were partly confirmed by the other CPE gene
expression datasets (Table 3).
ACE codes for the enzyme that converts angiotensin I to
angiotensin II by release of the terminal His-Leu [63]. This leads
to increased vasoconstriction and as a consequence hypertension.
Inhibitors of ACE are commonly used to treat hypertension. Our
findings, in combination with those of the literature, suggest that
the ICP regulation via the CPE may be different in mice and
humans.
PON1 is involved in the metabolism of toxic metabolites,
organophosphates, lactones and aromatic carboxylic acid esters
[64]. Differences in expression of PON1 in mouse and human CPE
may indicate that there are metabolic (clearance or transport)
differences between the CPE of human and mouse.
Finally, TRIM3 is involved in vesicular trafficking of targeted
organelles and modulation of kinesin superfamily protein (KIF)
motor function [65]. This might indicate that targeted vesicle
transport between the human and mouse CPE may be different.
Conclusion
The mouse may serve well as an animal model to study diseases
of the CPE. With a few single gene expression exceptions, the
mouse CPE transcriptome closely resembles human CPE
transcriptome. The data presented here could serve as a reference
to check whether a specific gene or function of interest differs in
expression between man and mouse and consequently can be
studied in the mouse or not. Further protein and functional studies
on single selected genes are needed to fully comprehend functional
CPE differences between man and mice.
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